Literature DB >> 11745331

Critical role of NK but not NKT cells in acute rejection of parental bone marrow cells in F1 hybrid mice.

K Suzue1, E L Reinherz, S Koyasu.   

Abstract

F1 hybrid mice vigorously reject transplanted parental bone marrow (BM) cells, which is a phenomenon called "hybrid resistance (HR)". Since NK1.1(+) cells play crucial role in HR, both NK1.1(+)CD3(+) NKT cells and NK1.1(+)CD3(-) NK cells have been possible candidates of effector cells. To elucidate the major effector cells in HR, we employed Rag-2(-/-) mice devoid of T, B, and NKT cells and cytokine receptor common gamma subunit and Rag-2 double-deficient (gamma(c)(-/-(y))-Rag-2(-/-)) mice lacking all lymphoid cells including NK cells. Rag-2(-/-) F1 hybrid mice rejected parental BM cells to the extent similar to wild-type (WT) F1 hybrids. In contrast, male gamma(c)(-/y)-Rag-2(-/-) F1 hybrid mice were unable to reject parental BM cells. After reconstitution with NK but not NKT cells, male gamma(c)(-/y)-Rag-2(-/-) F1 hybrid mice restored the ability to reject parental BM cells. Collectively, it is concluded that NKT cells play little role, if any, and NK cells are the only cells involved in HR.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11745331     DOI: 10.1002/1521-4141(200111)31:11<3147::aid-immu3147>3.0.co;2-f

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  9 in total

1.  Suppression of natural killer cell-mediated bone marrow cell rejection by CD4+CD25+ regulatory T cells.

Authors:  Isabel Barao; Alan M Hanash; William Hallett; Lisbeth A Welniak; Kai Sun; Doug Redelman; Bruce R Blazar; Robert B Levy; William J Murphy
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-27       Impact factor: 11.205

2.  Immunomodulatory effects induced by cytotoxic T lymphocyte antigen 4 immunoglobulin with donor peripheral blood mononuclear cell infusion in canine major histocompatibility complex-haplo-identical non-myeloablative hematopoietic cell transplantation.

Authors:  Yun Chen; Takahiro Fukuda; Monica S Thakar; Brian T Kornblit; Barry E Storer; Erlinda B Santos; Rainer Storb; Brenda M Sandmaier
Journal:  Cytotherapy       Date:  2011-08-17       Impact factor: 5.414

3.  NK cell patrolling and elimination of donor-derived dendritic cells favor indirect alloreactivity.

Authors:  Kym R Garrod; Feng-Chun Liu; Luette E Forrest; Ian Parker; Sang-Mo Kang; Michael D Cahalan
Journal:  J Immunol       Date:  2010-02-05       Impact factor: 5.422

4.  Differential Engraftment of Parental A20 PD-L1 WT and PD-L1 KO Leukemia Cells in Semiallogeneic Recipients in the Context of PD-L1/PD-1 Interaction and NK Cell-Mediated Hybrid Resistance.

Authors:  Maria-Luisa Del Rio; Jose-Antonio Perez-Simon; Jose-Ignacio Rodriguez-Barbosa
Journal:  Front Immunol       Date:  2022-06-20       Impact factor: 8.786

5.  Busulfan produces efficient human cell engraftment in NOD/LtSz-Scid IL2Rgamma(null) mice.

Authors:  Jun Hayakawa; Matthew M Hsieh; Naoya Uchida; Oswald Phang; John F Tisdale
Journal:  Stem Cells       Date:  2009-01       Impact factor: 6.277

6.  Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell function.

Authors:  Paolo Serafini; Kristen Meckel; Michael Kelso; Kimberly Noonan; Joseph Califano; Wayne Koch; Luigi Dolcetti; Vincenzo Bronte; Ivan Borrello
Journal:  J Exp Med       Date:  2006-11-13       Impact factor: 14.307

7.  NK Cell Alloreactivity against KIR-Ligand-Mismatched HLA-Haploidentical Tissue Derived from HLA Haplotype-Homozygous iPSCs.

Authors:  Hiroshi Ichise; Seiji Nagano; Takuya Maeda; Masaki Miyazaki; Yuki Miyazaki; Hiroto Kojima; Nobuyo Yawata; Makoto Yawata; Hidenori Tanaka; Hiroh Saji; Kyoko Masuda; Hiroshi Kawamoto
Journal:  Stem Cell Reports       Date:  2017-08-31       Impact factor: 7.765

8.  Therapeutic implications of NK cell regulation of allogeneic CD8 T cell-mediated immune responses stimulated through the direct pathway of antigen presentation in transplantation.

Authors:  J I Rodriguez-Barbosa; M C Ferreras; L Buhler; N D Jones; P Schneider; J A Perez-Simon; M L Del Rio
Journal:  MAbs       Date:  2018-09-05       Impact factor: 5.857

Review 9.  Advances in Allogeneic Cancer Cell Therapy and Future Perspectives on "Off-the-Shelf" T Cell Therapy Using iPSC Technology and Gene Editing.

Authors:  Yoshiki Furukawa; Yasuharu Hamano; Shuichi Shirane; Shintaro Kinoshita; Yoko Azusawa; Jun Ando; Hiromitsu Nakauchi; Miki Ando
Journal:  Cells       Date:  2022-01-13       Impact factor: 6.600

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.